Molecular basis of agonist binding to the type A cholecystokinin receptor

Pharmacol Toxicol. 2002 Dec;91(6):282-5. doi: 10.1034/j.1600-0773.2002.910603.x.

Abstract

The receptors for cholecystokinin (CCK) peptides are guanine nucleotide-binding protein-coupled receptors in the rhodopsin/beta-adrenergic receptor family. The molecular basis of natural ligand binding to the type A CCK receptor has been studied using ligand structure-activity series, receptor mutagenesis, and photoaffinity labeling studies. These have focused attention on the extracellular loop and tail domains, with the most direct insights coming from intrinsic photoaffinity labeling studies. A model of the binding of CCK to this receptor is consistent with all these studies. This model places the carboxyl terminus of CCK adjacent to the amino-terminal tail outside of transmembrane segment 1, the mid-region of the peptide adjacent to the third extracellular loop outside of transmembrane segment 7, and includes a charge-charge interaction between peptide residue tyrosine-sulfate 27 and the arginine residue in the second extracellular loop of the receptor in position 197.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Binding Sites
  • Molecular Conformation
  • Molecular Sequence Data
  • Mutagenesis
  • Rats
  • Receptors, Cholecystokinin / metabolism*
  • Structure-Activity Relationship

Substances

  • Receptors, Cholecystokinin